Iovance Biotherapeutics, Inc. IOVA EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s EV / sales?
- Iovance Biotherapeutics, Inc. (IOVA) reported EV / sales of 4.5× in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s EV / sales changed year-over-year?
- Iovance Biotherapeutics, Inc.'s EV / sales decreased by 0.8% year-over-year, from 4.6× to 4.5×.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s EV / sales?
- Over 2 years (2023 to 2025), Iovance Biotherapeutics, Inc.'s EV / sales has grown at a -95.3% compound annual growth rate (CAGR), from 1,661.4× to 3.7×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.